investor damages

Rosen Law Firm seeks lead plaintiffs in class action against $VITL over alleged misstatements regarding ERP system delays that caused missed 2025 guidance.

Eos Energy investors face May 5, 2026 deadline to join securities class action alleging false production capacity and operational claims that harmed shareholders.

Rosen Law Firm solicits $SMCI investors for class action alleging false statements about Chinese sales violating export controls. Lead plaintiff deadline: May 26, 2026.

Boston Scientific faces securities class action over alleged Electrophysiology segment disclosure failures. Investors must act by May 4, 2026 deadline.

Rosen Law Firm files UPST class action over Model 22 AI misrepresentations. Alleged false claims about accuracy rates and macroeconomic model sensitivity impact investor viability.

Rosen Law Firm seeks lead plaintiffs in class action against $NKTR over alleged false statements regarding REZOLVE-AA trial enrollment. Deadline: May 5, 2026.

Eos Energy ($EOSE) faces securities class action alleging false statements on production capacity, downtime, and guidance. May 5, 2026 deadline for investors to secure counsel.

Rosen Law Firm launches securities class action against Super Micro Computer ($SMCI) alleging false statements about Chinese sales and export control violations.

Securities class action filed against $ALIT alleges false statements on growth and dividend sustainability. Affected shareholders have until May 15, 2026 to seek counsel.

Class action filed against Franklin BSP Realty Trust alleging false statements about dividend sustainability. Investors who purchased shares between November 2024 and February 2026 may be eligible.

Rosen Law Firm alerts Gartner investors of May 18, 2026 deadline in securities class action alleging false growth targets.

Rosen Law Firm alerts $NKTR investors of May 5, 2026 deadline to join securities class action over alleged false statements regarding REZOLVE-AA trial enrollment protocols.

REGENXBIO ($RGNX) investors have until April 14, 2026 to join securities class action over allegedly misleading RGX-111 trial statements.

Apollo Global Management faces class action alleging executives made false statements about Jeffrey Epstein business dealings. Eligible investors purchased securities between May 2021 and February 2026.

Rosen Law Firm alerts $COTY investors of May 22 deadline in securities lawsuit alleging false statements on growth, margins, and segment performance.

Securities class action filed against $SLNO alleging false statements about DCCR drug safety. Investors have until May 5, 2026 deadline to join lawsuit.

Rosen Law Firm initiates securities class action against $NKTR for alleged false statements regarding enrollment protocols in REZOLVE-AA trial. Lead plaintiff deadline: May 5, 2026.

Schall Law Firm seeks Eos Energy ($EOSE) investors from November 2025–February 2026 for class action over alleged false statements regarding production, capacity utilization, and guidance.

Schall Law Firm seeks lead plaintiffs in class action against REGENXBIO for allegedly concealing negative efficacy and safety data on RGX-111 candidate drug.

Rosen Law Firm solicits Corcept investors in securities class action over alleged misstatements regarding relacorilant clinical trials and FDA approval prospects.